Liver Metastasis – Medxy AI

MTFP1 and Metabolic Reprogramming: Unlocking New Targets in Pancreatic Cancer Liver Metastasis

By MedXY 10/14/2026

MTFP1 promotes pancreatic ductal adenocarcinoma liver metastasis by enhancing mitochondrial oxidative phosphorylation via the ROS/PI3K/AKT/c-MYC/SLC1A5 axis, revealing a promising therapeutic target to reverse tumor immune suppression and reduce metastatic colonization.

Gastroenterology news Oncology Public Health

Impact of Medicaid Expansion on Survival in Colorectal Cancer with Liver Metastasis: A Population-Based Analysis

By MedXY 10/06/2026

Medicaid expansion under the Affordable Care Act is associated with reduced mortality in patients under 65 diagnosed with colorectal cancer and synchronous liver metastasis, notably improving outcomes for those receiving surgical and systemic therapies.

General Surgery Hematology-Oncology news

Circulating Exosomal microRNA Signature Enhances Preoperative Detection of Occult Liver Metastases in Pancreatic Cancer

By MedXY 09/07/2026

A multicenter study developed a robust exosomal microRNA-based model enabling preoperative detection of occult liver micrometastasis in pancreatic ductal adenocarcinoma, improving risk stratification and guiding treatment sequencing.